GlucoTrack, Inc. short interest in 2024

In 2024, GlucoTrack, Inc.'s disclosed short interest ran from 0.19% of shares outstanding on 31 Jan 2024 to 0.28% on 30 Apr 2024, a change of +0.09 percentage points. The year's high was 0.40% on 15 Apr 2024 and its low 0.11% on 29 Feb 2024, averaging 0.26% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 31 Jan 2024. Full history: GlucoTrack, Inc..

Cite this page

Plain

Short position data for GlucoTrack, Inc. short interest in 2024: FINRA, compiled by howshorted.com, settlement date 30 Apr 2024. https://howshorted.com/us/company/gctk/2024/

Wikipedia

<ref>{{cite web |title=GlucoTrack, Inc. short interest in 2024 short position data |url=https://howshorted.com/us/company/gctk/2024/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2024-04-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-glucotrack-inc-short-interest-in-2024-2024-04-30,
  title        = {GlucoTrack, Inc. short interest in 2024 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/gctk/2024/}},
  note         = {Data: FINRA, settlement date 30 Apr 2024; accessed 2026-10-13},
  year         = {2024}
}

By year: 2022 · 2023 · 2024 · 2026

2024 in figures

Start of year: 0.19% (31 Jan 2024)
End of year: 0.28% (30 Apr 2024)
Change: +0.09 pp
High: 0.40% (15 Apr 2024)
Low: 0.11% (29 Feb 2024)
Average: 0.26%
Highest days to cover: 1.00 (31 Jan 2024)
SEC filings marked: 4

Every report in 2024

GlucoTrack, Inc. short interest in 2024
Settlement	Short interest	Days to cover	Filings since previous
31 Jan 2024	0.19%	1.00
15 Feb 2024	0.21%	1.00
29 Feb 2024	0.11%	1.00
28 Mar 2024	0.37%	1.00	10-K filed
15 Apr 2024	0.40%	1.00
30 Apr 2024	0.28%	1.00

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.